174
Participants
Start Date
March 31, 2004
Study Completion Date
March 31, 2007
ALVAC-HIV (vCP1452)
experimental vaccine
LIPO-5
experimental vaccine
NY Blood Ctr./Bronx CRS, The Bronx
Vanderbilt Vaccine CRS, Nashville
FHCRC/UW Vaccine CRS, Seattle
Alabama Vaccine CRS, Birmingham
Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research,Project SAVE-Baltimore, Baltimore
Project Brave HIV Vaccine CRS, Baltimore
Saint Louis Univ. School of Medicine, HVTU, St Louis
Brigham and Women's Hosp. CRS, Boston
Fenway Community Health Clinical Research Site (FCHCRS), Boston
Univ. of Rochester HVTN CRS, Rochester
Miriam Hospital's HVTU, Providence
ANRS, Emerging Infectious Diseases
OTHER_GOV
National Institute of Allergy and Infectious Diseases (NIAID)
NIH